F Beby1, O Roche, C Burillon, P Denis. 1. Department of Ophthalmology, Edouard Herriot Hospital, Lyon, France. francis.beby@libertysurf.fr
Abstract
PURPOSE: To report the first case in which Coats' disease was observed with infantile cataract in a girl with Turner syndrome (TS). MATERIALS AND METHODS: We examined a 4-year-old female infant with TS who was referred with a diagnosis of leukocoria in the left eye. RESULTS AND DISCUSSION: Examination under anaesthesia revealed a bilateral punctate cataract and left eye fundus showed vascular retinal abnormalities typical of Coats' disease. Cryotherapy was performed on the telangiectatic vessels and the child was followed up for a period of 12 months. Despite cryotherapy resulting in regression of the peripheral exudates, an exudative maculopathy persisted with poor visual outcome. We suggest that Coats' disease should be considered as a rare ocular manifestation in TS.
PURPOSE: To report the first case in which Coats' disease was observed with infantile cataract in a girl with Turner syndrome (TS). MATERIALS AND METHODS: We examined a 4-year-old female infant with TS who was referred with a diagnosis of leukocoria in the left eye. RESULTS AND DISCUSSION: Examination under anaesthesia revealed a bilateral punctate cataract and left eye fundus showed vascular retinal abnormalities typical of Coats' disease. Cryotherapy was performed on the telangiectatic vessels and the child was followed up for a period of 12 months. Despite cryotherapy resulting in regression of the peripheral exudates, an exudative maculopathy persisted with poor visual outcome. We suggest that Coats' disease should be considered as a rare ocular manifestation in TS.
Authors: Vincent B Ho; Vladimir K Bakalov; Margaret Cooley; Phillip L Van; Maureen N Hood; Thomas R Burklow; Carolyn A Bondy Journal: Circulation Date: 2004-09-07 Impact factor: 29.690
Authors: Priscila H A Oliveira; Beatriz S Souza; Eimi N Pacheco; Michele S Menegazzo; Ivan S Corrêa; Paulo R G Zen; Rafael F M Rosa; Claudia C Cesa; Lucia C Pellanda; Manuel A P Vilela Journal: Arq Bras Cardiol Date: 2018-01 Impact factor: 2.000